Shafa Darou Pharmaceutical Investment Co (XTEH:SHFA1) COGS-to-Revenue : 0.00 (As of . 20)

View and export this data going back to 2018. Start your Free Trial

What is Shafa Darou Pharmaceutical Investment Co COGS-to-Revenue?

Shafa Darou Pharmaceutical Investment Co's Cost of Goods Sold for the six months ended in . 20 was IRR0.00 Mil. Its Revenue for the six months ended in . 20 was IRR0.00 Mil.

Shafa Darou Pharmaceutical Investment Co's COGS to Revenue for the six months ended in . 20 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Shafa Darou Pharmaceutical Investment Co's Gross Margin % for the six months ended in . 20 was N/A%.

Shafa Darou Pharmaceutical Investment Co COGS-to-Revenue Historical Data

The historical data trend for Shafa Darou Pharmaceutical Investment Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shafa Darou Pharmaceutical Investment Co COGS-to-Revenue Chart

Shafa Darou Pharmaceutical Investment Co Annual Data

Trend

COGS-to-Revenue

Shafa Darou Pharmaceutical Investment Co Semi-Annual Data

COGS-to-Revenue

Shafa Darou Pharmaceutical Investment Co COGS-to-Revenue Calculation

Shafa Darou Pharmaceutical Investment Co's COGS to Revenue for the fiscal year that ended in . 20 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=		/
	=

Shafa Darou Pharmaceutical Investment Co's COGS to Revenue for the quarter that ended in . 20 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=		/
	=

Shafa Darou Pharmaceutical Investment Co (XTEH:SHFA1) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Shafa Darou Pharmaceutical Investment Co's Gross Margin % for the six months ended in . 20 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	/
	=	N/A %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Shafa Darou Pharmaceutical Investment Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Shafa Darou Pharmaceutical Investment Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Shafa Darou Pharmaceutical Investment Co (XTEH:SHFA1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shafa Darou Pharmaceutical Investment Co (XTEH:SHFA1) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

Fakhar Moghadam Street, Dadman Street, No. 13, At the corner of East 4th Golbarg Alley, Shahrak-e Gharb, Tehran, IRN

Website

http://www.shafadarou.org

Shafa Darou Pharmaceutical Investment Co is a pharmaceutical holding company. Along with its subsidiaries it produces injectable, non-injectable, and antibiotics.

Shafa Darou Pharmaceutical Investment Co (XTEH:SHFA1) Headlines

No Headlines